Splenic Irradiation Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with Myelofibrosis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Polverelli N, Hernandez-Boluda J, Gagelmann N, Gurnari C, Malagola M, Duarte F Bone Marrow Transplant. 2024; 60(1):10-18.
PMID: 39402189 DOI: 10.1038/s41409-024-02437-6.
Are transplant indications changing for myelofibrosis?.
Palmer J Hematology Am Soc Hematol Educ Program. 2023; 2023(1):676-681.
PMID: 38066916 PMC: 10727025. DOI: 10.1182/hematology.2023000453.
References
1.
Arber D, Orazi A, Hasserjian R, Thiele J, Borowitz M, Le Beau M
. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391-405.
DOI: 10.1182/blood-2016-03-643544.
View
2.
Tefferi A
. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 2020; 96(1):145-162.
DOI: 10.1002/ajh.26050.
View
3.
Yoon J, Pettit K
. Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directions. Expert Rev Hematol. 2021; 14(7):607-619.
DOI: 10.1080/17474086.2021.1944096.
View
4.
Verstovsek S, Mesa R, Gotlib J, Levy R, Gupta V, Dipersio J
. A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med. 2012; 366(9):799-807.
PMC: 4822164.
DOI: 10.1056/NEJMoa1110557.
View
5.
Shimomura Y, Hara M, Katoh D, Hashimoto H, Ishikawa T
. Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome. Ann Hematol. 2018; 97(6):1049-1056.
DOI: 10.1007/s00277-018-3278-9.
View